Biologicals

Typhoid fever

Typhoid polysaccharide vaccine

Title: Requirements for Vi Polysaccharide Typhoid Vaccine; Adopted 1992, TRS No 840, Annex 1

Typhoid vaccine, live attenuated

Title: Requirements for Typhoid Vaccine (Live, attenuated, Ty 21a, Oral); Adopted at ECBS 1983 Reference:TRS No 700, Annex 3

Typhoid vaccine

Title: Requirements for Typhoid Vaccine; Adopted 1966, TRS No 361, Annex 4

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



NEW PUBLICATIONS

UPCOMING EVENTS


  • WHO Informal Consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products including biosimilars, Seoul, Republic of Korea, 27-28 April 2017
  • Working Group meeting on revision of WHO TRS 941, Annex 5: WHO biosafety risk assessment and Guidelines for the production and quality control of human influenza pandemic vaccines, Geneva, Switzerland, 9-10 May 2017
  • Working group meeting on Hepatitis E Vaccine, Geneva, Switzerland, 11-12 May 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971